Attached files
| file | filename |
|---|---|
| S-1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_s1.htm |
| EX-5.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex5-1.htm |
| EX-21.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex21-1.htm |
| EX-23.1 - NAVIDEA BIOPHARMACEUTICALS, INC. | v170098_ex23-1.htm |
Exhibit
24.1
POWER OF
ATTORNEY
Each of the undersigned officers and
directors of Neoprobe Corporation, a Delaware corporation (the "Company"),
hereby appoints David C. Bupp and Brent L. Larson as the undersigned’s
attorney-in-fact, or either them individually as the undersigned’s
attorney-in-fact, in his or her name and on his or her behalf, and in any and
all capacities stated below, to sign or cause to be filed with the Securities
and Exchange Commission (the "Commission"), the Company's registration statement
on Form S-1 (the "Registration Statement") to register under the Securities Act
of 1933, as amended, the sale of up to 15,500,000 shares of common stock, $.001
par value, of the Company, and any and all amendments, including post-effective
amendments, to the Registration Statement, hereby granting unto such
attorneys-in-fact, and to each of them, full power and authority to do and
perform in the name of and on behalf of the undersigned, in any and all such
capacities, every act and thing whatsoever necessary to be done in and about the
premises as fully as the undersigned could or might do in person, hereby
granting to each such attorney-in-fact full power of substitution and
revocation, and hereby ratifying all that any such attorney-in-fact or his
substitute may do by virtue hereof.
IN WITNESS WHEREOF, the undersigned
have executed this Power of Attorney effective as of December 21,
2009.
|
Signature
|
Title
|
||
|
/s/ David C, Bupp
|
President,
Chief Executive Officer
|
||
|
David
C. Bupp
|
and
Director
|
||
|
(principal
executive officer)
|
|||
|
/s/ Brent L. Larson
|
Vice
President, Finance, Chief
|
||
|
Brent
L. Larson
|
Financial
Officer, Treasurer and Secretary
|
||
|
(principal
financial officer and principal
|
|||
|
accounting
officer)
|
|||
|
/s/ Carl J. Aschinger,
Jr.
|
Chairman
of the Board of Directors
|
||
|
Carl
J. Aschinger, Jr.
|
|||
|
/s/ Reuven Avital
|
Director
|
||
|
Reuven
Avital
|
|||
|
/s/ Kirby I. Bland,
M.D.
|
Director
|
||
|
Kirby
I. Bland, M.D.
|
|||
|
/s/ Owen E. Johnson,
M.D.
|
Director
|
||
|
Owen
E. Johnson, M.D.
|
|||
|
/s/ Fred B. Miller
|
Director
|
||
|
Fred
B. Miller
|
|||
|
/s/ Gordon A. Troup
|
Director
|
||
|
Gordon
A. Troup
|
|||
|
/s/ J. Frank Whitley,
Jr.
|
Director
|
||
|
J. Frank Whitley,
Jr.
|
|